End-of-day quote
BURSA MALAYSIA
03:30:00 25/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.365
MYR
|
0.00%
|
|
-2.67%
|
-5.19%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
538.1
|
1,309
|
969.4
|
713.9
|
554.9
|
526
|
-
|
Enterprise Value (EV)
1 |
538.1
|
1,309
|
969.4
|
713.9
|
554.9
|
526
|
526
|
P/E ratio
|
-3.6
x
|
47.6
x
|
5.63
x
|
-1.18
x
|
-6.8
x
|
10.4
x
|
10.7
x
|
Yield
|
4.13%
|
2.2%
|
12.6%
|
3.49%
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.19
x
|
0.48
x
|
0.2
x
|
0.2
x
|
0.16
x
|
0.15
x
|
0.15
x
|
EV / Revenue
|
0.19
x
|
0.48
x
|
0.2
x
|
0.2
x
|
0.16
x
|
0.15
x
|
0.15
x
|
EV / EBITDA
|
4.12
x
|
12.9
x
|
2.83
x
|
-1.41
x
|
14.1
x
|
2.93
x
|
2.87
x
|
EV / FCF
|
4.64
x
|
-31.1
x
|
-10.3
x
|
-3.54
x
|
-59.7
x
|
18.3
x
|
15.2
x
|
FCF Yield
|
21.6%
|
-3.21%
|
-9.74%
|
-28.2%
|
-1.68%
|
5.47%
|
6.58%
|
Price to Book
|
1.59
x
|
3.88
x
|
2.15
x
|
-2.87
x
|
-1.78
x
|
-2.15
x
|
-2.61
x
|
Nbr of stocks (in thousands)
|
13,06,149
|
13,08,529
|
13,09,959
|
13,09,959
|
14,41,230
|
14,41,230
|
-
|
Reference price
2 |
0.4120
|
1.000
|
0.7400
|
0.5450
|
0.3850
|
0.3650
|
0.3650
|
Announcement Date
|
20/02/20
|
17/03/21
|
17/02/22
|
27/02/23
|
29/02/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2,821
|
2,725
|
4,815
|
3,511
|
3,404
|
3,507
|
3,577
|
EBITDA
1 |
130.6
|
101.2
|
342.3
|
-505.3
|
39.24
|
179.5
|
183.1
|
EBIT
1 |
-153
|
68.86
|
308.9
|
-541.7
|
-5.106
|
140.3
|
137
|
Operating Margin
|
-5.42%
|
2.53%
|
6.41%
|
-15.43%
|
-0.15%
|
4%
|
3.83%
|
Earnings before Tax (EBT)
1 |
-191.9
|
35.79
|
277.1
|
-580.8
|
-62.82
|
79.4
|
76.4
|
Net income
1 |
-149.2
|
27.49
|
172.2
|
-607.3
|
-77.45
|
50.6
|
48.7
|
Net margin
|
-5.29%
|
1.01%
|
3.58%
|
-17.3%
|
-2.28%
|
1.44%
|
1.36%
|
EPS
2 |
-0.1144
|
0.0210
|
0.1315
|
-0.4636
|
-0.0566
|
0.0350
|
0.0340
|
Free Cash Flow
1 |
116
|
-42.04
|
-94.44
|
-201.6
|
-9.295
|
28.8
|
34.6
|
FCF margin
|
4.11%
|
-1.54%
|
-1.96%
|
-5.74%
|
-0.27%
|
0.82%
|
0.97%
|
FCF Conversion (EBITDA)
|
88.83%
|
-
|
-
|
-
|
-
|
16.04%
|
18.9%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
56.92%
|
71.05%
|
Dividend per Share
2 |
0.0170
|
0.0220
|
0.0930
|
0.0190
|
-
|
-
|
-
|
Announcement Date
|
20/02/20
|
17/03/21
|
17/02/22
|
27/02/23
|
29/02/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
116
|
-42
|
-94.4
|
-202
|
-9.3
|
28.8
|
34.6
|
ROE (net income / shareholders' equity)
|
-35.2%
|
8.14%
|
43.7%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-8.53%
|
1.73%
|
8.97%
|
-29.8%
|
-4.13%
|
2.6%
|
2.4%
|
Assets
1 |
1,750
|
1,586
|
1,919
|
2,038
|
1,875
|
1,946
|
2,029
|
Book Value Per Share
2 |
0.2600
|
0.2600
|
0.3400
|
-0.1900
|
-0.2200
|
-0.1700
|
-0.1400
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
72.7
|
9.25
|
30.4
|
59.3
|
-
|
-
|
-
|
Capex / Sales
|
2.58%
|
0.34%
|
0.63%
|
1.69%
|
-
|
-
|
-
|
Announcement Date
|
20/02/20
|
17/03/21
|
17/02/22
|
27/02/23
|
29/02/24
|
-
|
-
|
Last Close Price
0.365
MYR Average target price
0.34
MYR Spread / Average Target -6.85% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.19% | 112M | | +31.10% | 78.4B | | +1.90% | 25.12B | | +12.73% | 8.62B | | +2.20% | 8.55B | | -30.63% | 6.91B | | +15.63% | 5.34B | | +1.79% | 4.17B | | -9.01% | 3.82B | | -8.36% | 3.37B |
Pharmaceuticals Wholesale
|